The Binding Site, Birmingham, UK, has added two native tick-borne encephalitis (TBE) viral antigens to its portfolio of products for in vitro diagnostics manufacturing and research. Both antigens are designed for use as components within a variety of enzyme immunoassay procedures. The antigens include TBE virus standard AG category number BA112VSL and TBE virus premium AG category number BA112VS.
The antigens have a shelf-life stability of 10 years from the date of manufacture and exhibit exceptional lot-to-lot consistency. Proprietary manufacturing techniques ensure exceptional purity. The antigens are available in standard 1-mg vials and in bulk packaging.
For more information, visit the Binding Site.
